LAG3 and neoplasm: Besides the inherent limitations of the TIDE analysis, one possible explanation would likely be that the T cell dysfunction with multiple alternative immune checkpoints including CTLA-4 and LAG3 within the tumor microenvironment is beyond the salvage of the single-target immune checkpoint inhibitor (Thommen and Schumacher, 2018).